賽倫生物(688163.SH):目前正在開展眼鏡蛇毒、蝮蛇毒、五步蛇毒的快速診斷試劑研發工作
格隆匯3月1日丨賽倫生物(688163.SH)近日在接待機構投資者調研時表示,公司佈局蛇毒快速診斷試劑研發項目是基於臨牀蛇傷診療需求、公司多年深耕蛇傷急救市場的優勢以及對蛇毒毒素的多年研究積累和技術優勢。目前,蛇傷救治仍然侷限於依據攻擊蛇的大致外形、病人傷口蛇牙咬痕、全身的臨牀表現或者外部實驗室檢測等輔助手段來檢測毒素,從而判斷是何種毒蛇咬傷,進而採取相應的治療措施,仍然缺乏直接、快速、有效的技術診斷措施來鑑別是何種蛇傷。
目前公司正在開展眼鏡蛇毒、蝮蛇毒、五步蛇毒的快速診斷試劑研發工作,該試劑採用膠體金技術,在檢測卡中滴入樣本液後觀察檢測線位置是否有紅色線條出現的方式進行判讀檢定,以期為醫患提供靈敏度高、特異性好、方便快速、結果判讀直接明瞭的檢測試劑,以確保在蛇傷患者急救中選用正確的藥物和治療方案,並節省寶貴的時間來搶救患者的生命,同時,還可用於跟蹤治療過程中的體內毒素狀況,輔助臨牀判斷是否還需要增加抗蛇毒血清的應用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.